PTThe Paper Trail Project
Sourced institutional rolesLDA lobbying records

DANIEL M TODD

DANIEL M TODD appears as a registered lobbyist in federal Lobbying Disclosure Act records connected to organizations tracked by Paper Trail.

Data updated Aug 31, 2026

Source-backed chronology

Career Timeline

Dates not reported

Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid

Federal government

Inspect source ↗

Documented career transitions

Revolving Door

Congress → Lobbying

Federal governmentSenior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & MedicaidMcKessonRegistered lobbyist

Federal LDA filings

Lobbying Activity

MCKESSON CORPORATION1st Quarter (Jan 1 - Mar 31) 2019

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Issues as they related to opioid abuse policy. Medicare physician payment.

LDA filing ↗
MCKESSON CORPORATION1st Quarter (Jan 1 - Mar 31) 2021

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Centers for Medicare and Medicaid Innovation. Prescription Drug Price Reform. COVID-19 Response.

LDA filing ↗
MCKESSON CORPORATION2nd Quarter (Apr 1 - June 30) 2024

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Emergency Preparedness. Drug shortages.

LDA filing ↗
MCKESSON CORPORATION3rd Quarter (July 1 - Sep 30) 2022

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Strategic National Stockpile. COVID-19 Response.

LDA filing ↗
MCKESSON CORPORATION2nd Quarter (Apr 1 - June 30) 2023

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Strategic National Stockpile. COVID-19 Response.

LDA filing ↗
MCKESSON CORPORATION3rd Quarter (July 1 - Sep 30) 2019

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Issues as they related to opioid abuse policy. Medicare physician payment.

LDA filing ↗
MCKESSON CORPORATION3rd Quarter (July 1 - Sep 30) 2024

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Emergency Preparedness. Drug shortages.

LDA filing ↗
MCKESSON CORPORATION3rd Quarter (July 1 - Sep 30) 2025

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Transparency Requirements. Emergency Preparedness.

LDA filing ↗
MCKESSON CORPORATION1st Quarter (Jan 1 - Mar 31) 2017

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare coding, coverage and payment for clinical laboratory tests. General Medicare/Medicaid Issues.

LDA filing ↗
MCKESSON CORPORATION4th Quarter (Oct 1 - Dec 31) 2023

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Emergency Preparedness.

LDA filing ↗
MCKESSON CORPORATION3rd Quarter (July 1 - Sep 30) 2023

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Emergency Preparedness.

LDA filing ↗
MCKESSON CORPORATION4th Quarter (Oct 1 - Dec 31) 2020

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Centers for Medicare and Medicaid Innovation. Prescription Drug Price Reform.

LDA filing ↗
MCKESSON CORPORATION1st Quarter (Jan 1 - Mar 31) 2024

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Emergency Preparedness.

LDA filing ↗
MCKESSON CORPORATION1st Quarter (Jan 1 - Mar 31) 2018

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Issues as they related to opioid abuse policy.

LDA filing ↗
MCKESSON CORPORATION4th Quarter (Oct 1 - Dec 31) 2017

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Issues as they related to opioid abuse policy.

LDA filing ↗
MCKESSON CORPORATION3rd Quarter (July 1 - Sep 30) 2015

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare coding, coverage and payment for clinical laboratory tests. General Medicare/Medicaid Issues.

LDA filing ↗
MCKESSON CORPORATION2nd Quarter (Apr 1 - June 30) 2026

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Transparency Requirements. Emergency Preparedness.

LDA filing ↗
MCKESSON CORPORATION4th Quarter (Oct 1 - Dec 31) 2025

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Transparency Requirements. Emergency Preparedness.

LDA filing ↗
MCKESSON CORPORATION4th Quarter (Oct 1 - Dec 31) 2015

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare coding, coverage and payment for clinical laboratory tests. General Medicare/Medicaid Issues.

LDA filing ↗
MCKESSON CORPORATION2nd Quarter (Apr 1 - June 30) 2017

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. General Medicare/Medicaid Issues.

LDA filing ↗
MCKESSON CORPORATION3rd Quarter (July 1 - Sep 30) 2016

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare coding, coverage and payment for clinical laboratory tests. General Medicare/Medicaid Issues.

LDA filing ↗
MCKESSON CORPORATION2nd Quarter (Apr 1 - June 30) 2021

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Centers for Medicare and Medicaid Innovation. Prescription Drug Price Reform. COVID-19 Response.

LDA filing ↗
MCKESSON CORPORATION4th Quarter (Oct 1 - Dec 31) 2021

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Strategic National Stockpile. COVID-19 Response.

LDA filing ↗
MCKESSON CORPORATION3rd Quarter (July 1 - Sep 30) 2017

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Issues as they related to opioid abuse policy.

LDA filing ↗
MCKESSON CORPORATION2nd Quarter (Apr 1 - June 30) 2015

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare coding, coverage and payment for clinical laboratory tests. General Medicare/Medicaid Issues.

LDA filing ↗
MCKESSON CORPORATION1st Quarter (Jan 1 - Mar 31) 2016

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare coding, coverage and payment for clinical laboratory tests. General Medicare/Medicaid Issues.

LDA filing ↗
MCKESSON CORPORATION2nd Quarter (Apr 1 - June 30) 2016

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare coding, coverage and payment for clinical laboratory tests. General Medicare/Medicaid Issues.

LDA filing ↗
MCKESSON CORPORATION3rd Quarter (July 1 - Sep 30) 2018

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Issues as they related to opioid abuse policy. Medicare physician payment.

LDA filing ↗
MCKESSON CORPORATION2nd Quarter (Apr 1 - June 30) 2018

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Issues as they related to opioid abuse policy. Medicare physician payment.

LDA filing ↗
MCKESSON CORPORATION3rd Quarter (July 1 - Sep 30) 2021

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. COVID-19 Response.

LDA filing ↗
MCKESSON CORPORATION1st Quarter (Jan 1 - Mar 31) 2023

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Strategic National Stockpile. COVID-19 Response.

LDA filing ↗
MCKESSON CORPORATION4th Quarter (Oct 1 - Dec 31) 2022

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Strategic National Stockpile. COVID-19 Response.

LDA filing ↗
MCKESSON CORPORATION2nd Quarter (Apr 1 - June 30) 2025

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Transparency Requirements. Emergency Preparedness.

LDA filing ↗
MCKESSON CORPORATION4th Quarter (Oct 1 - Dec 31) 2016

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare coding, coverage and payment for clinical laboratory tests. General Medicare/Medicaid Issues.

LDA filing ↗
MCKESSON CORPORATION4th Quarter (Oct 1 - Dec 31) 2019

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Issues as they related to opioid abuse policy. Medicare physician payment.

LDA filing ↗
MCKESSON CORPORATION1st Quarter (Jan 1 - Mar 31) 2015

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare coding, coverage and payment for clinical laboratory tests. General Medicare/Medicaid Issues.

LDA filing ↗
MCKESSON CORPORATION2nd Quarter (Apr 1 - June 30) 2019

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Issues as they related to opioid abuse policy. Medicare physician payment.

LDA filing ↗
MCKESSON CORPORATION4th Quarter (Oct 1 - Dec 31) 2018

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Issues as they related to opioid abuse policy. Medicare physician payment.

LDA filing ↗
MCKESSON CORPORATION4th Quarter (Oct 1 - Dec 31) 2024

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Emergency Preparedness. Drug Shortages.

LDA filing ↗
MCKESSON CORPORATION1st Quarter (Jan 1 - Mar 31) 2025

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Emergency Preparedness.

LDA filing ↗
MCKESSON CORPORATION1st Quarter (Jan 1 - Mar 31) 2026

Registrant: TODD STRATEGY GROUP · Medicare/Medicaid

General Medicare/Medicaid Issues. Transparency Requirements. Emergency Preparedness.

LDA filing ↗